These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15609901)

  • 21. [Early insulin administration in obese patients with type 2 diabetes makes sense--pro].
    Dreyer M
    Dtsch Med Wochenschr; 2008 Apr; 133(17):919. PubMed ID: 18415917
    [No Abstract]   [Full Text] [Related]  

  • 22. [Insulin therapy in type 2 diabetes: short-acting insulin analog has advantages].
    MMW Fortschr Med; 2006 Jun; 148(26):56-7. PubMed ID: 16875384
    [No Abstract]   [Full Text] [Related]  

  • 23. Type II diabetes: insulin versus oral agents.
    Chalmers TC
    N Engl J Med; 1986 Nov; 315(19):1233-4. PubMed ID: 3531868
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of insulin to improve treatment in type 2 diabetes.
    Hill J
    Nurs Times; 2005 Jul 12-18; 101(28):32-4. PubMed ID: 16047998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of basal insulin in type 2 diabetes management.
    Brunton SA; White JR; Renda SM
    J Fam Pract; 2005 Oct; Suppl():S1-8. PubMed ID: 16271258
    [No Abstract]   [Full Text] [Related]  

  • 26. [Type 2 diabetes: new insulins and new therapeutic strategies].
    Sauvanet JP
    Diabetes Metab; 2004 Nov; 30(5):478-80. PubMed ID: 15682547
    [No Abstract]   [Full Text] [Related]  

  • 27. Dramatic improvement of subcutaneous insulin resistance with nafamostat ointment treatment.
    Kawashima S; Kaneto H; Sakamoto K; Honsho I; Yasuda T; Kuroda A; Shiraiwa T; Kasami R; Matsuoka TA; Yamasaki Y; Matsuhisa M
    Diabetes Care; 2008 Mar; 31(3):e11. PubMed ID: 18308674
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhaled insulin (exubera).
    Med Lett Drugs Ther; 2006 Jul; 48(1239):57-8. PubMed ID: 16841019
    [No Abstract]   [Full Text] [Related]  

  • 29. [Towards earlier nd more aggressive insulin therapy in type 2 diabetic patients].
    Passa P
    Diabetes Metab; 2001 Nov; 27(5 Pt 3):S5-6. PubMed ID: 11910978
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus.
    Ersoy A; Ersoy C; Altinay T
    Nephrol Dial Transplant; 2006 Feb; 21(2):553-4. PubMed ID: 16221693
    [No Abstract]   [Full Text] [Related]  

  • 31. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW
    J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical perspectives in type 2 diabetes care: optimizing glycemic control with insulin therapy.
    Diabetes Educ; 2005; Suppl():1-14; quiz 15-6. PubMed ID: 15786628
    [No Abstract]   [Full Text] [Related]  

  • 34. Insulin therapy for type 2 diabetes. Getting started.
    Snyder C; Hirsch IB
    Diabetes Self Manag; 2008; 25(4):30, 32-3, 35-6. PubMed ID: 18717025
    [No Abstract]   [Full Text] [Related]  

  • 35. [Optimal therapeutic strategy in type 2 diabetes mellitus].
    Scherbaum WA; Nitschmann S
    Internist (Berl); 2009 Feb; 50(2):244-8. PubMed ID: 19183919
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intensive insulin therapy in type 2 diabetes: obstacles: observance and elements of response].
    Reach G
    Journ Annu Diabetol Hotel Dieu; 2007; ():89-102. PubMed ID: 18610761
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin therapy for type 2 diabetes. Why it's often necessary.
    Ullman K
    Diabetes Self Manag; 2006; 23(5):16, 19-20, 23. PubMed ID: 17022123
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chronic inflammation can cause type 2 diabetes].
    Sjöholm A; Nyström T
    Lakartidningen; 2004 May; 101(19):1716-21. PubMed ID: 15188586
    [No Abstract]   [Full Text] [Related]  

  • 39. Insulin resistance determines efficacy of glimepiride in Type 2 diabetic patients not well controlled by diet alone.
    Shimizu H; Monden T; Nagai T; Shoda Y; Sato T; Yamada M; Mori M
    Diabet Med; 2005 Feb; 22(2):225-6. PubMed ID: 15660744
    [No Abstract]   [Full Text] [Related]  

  • 40. Conventional therapy with insulin.
    Nattrass M
    Postgrad Med; 2002 Nov; 112(5 Suppl Designer):13-6. PubMed ID: 19667600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.